HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes A Bogaards Selected Research

Infections

1/2022Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule.
1/2021Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
1/2019Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
1/2017What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies.
11/2016Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
1/2016A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
1/2015Estimating seroprevalence of human papillomavirus type 16 using a mixture model with smoothed age-dependent mixing proportions.
1/2013Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection.
2/2012Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening.
7/2011Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johannes A Bogaards Research Topics

Disease

15Infections
01/2022 - 02/2003
8Neoplasms (Cancer)
11/2023 - 07/2011
7Papillomavirus Infections
01/2022 - 12/2011
6Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2023 - 01/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2015 - 07/2011
3Acquired Immunodeficiency Syndrome (AIDS)
02/2006 - 02/2003
2Warts (Wart)
01/2021 - 01/2017
2HIV Infections (HIV Infection)
02/2006 - 02/2003
1Fatigue
10/2023
1Myositis (Idiopathic Inflammatory Myopathies)
10/2023
1Anus Neoplasms (Anal Cancer)
01/2020
1Hepatitis B
01/2019
1Coinfection
01/2019
1Carcinoma (Carcinomatosis)
05/2015
1Carcinogenesis
07/2011
1Disease Progression
10/2003
1Viremia
10/2003

Drug/Important Bio-Agent (IBA)

21VaccinesIBA
11/2023 - 10/2003
4DNA (Deoxyribonucleic Acid)IBA
01/2019 - 04/2010
3Papillomavirus Vaccines (HPV Vaccines)IBA
01/2022 - 02/2013
2Combined VaccinesIBA
01/2020 - 01/2018
2AntibodiesIBA
01/2015 - 07/2006
1Prednisone (Sone)FDA LinkGeneric
10/2023
1GlucocorticoidsIBA
10/2023
1SteroidsIBA
10/2023
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2023
1insulin receptor-related receptor (IRR)IBA
01/2023
1Doxycycline (Periostat)FDA LinkGeneric
01/2017
1Azithromycin (Zithromax)FDA LinkGeneric
01/2017
1Viral AntigensIBA
01/2015
1CR3022IBA
07/2006
1Monoclonal AntibodiesIBA
07/2006
1RNA (Ribonucleic Acid)IBA
02/2006
1AIDS VaccinesIBA
10/2003

Therapy/Procedure

2Highly Active Antiretroviral Therapy (HAART)
02/2006 - 02/2003
1Therapeutics
02/2003